{"data":[{"accessionNo":"0001674324-26-000008","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS, INC.","ticker":"TRDA","personName":"5AM Ventures V, L.P.","relationship":"Affiliated stockholder","securityClass":"Common Stock","broker":"Goldman Sachs & Co. LLC","unitsToSell":165578,"aggregateMarketValue":1084536,"unitsOutstanding":38820616,"approxSaleDate":"2026-07-30","exchange":"Nasdaq","filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001674324-26-000006","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS, INC.","ticker":"TRDA","personName":"5AM Ventures V, L.P.","relationship":"Affiliated stockholder","securityClass":"Common Stock","broker":"Goldman Sachs & Co. LLC","unitsToSell":331156,"aggregateMarketValue":2169072,"unitsOutstanding":38820616,"approxSaleDate":"2026-07-30","exchange":"Nasdaq","filedAt":"2026-07-30","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-004000","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"NATARAJAN SETHURAMAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25907,"aggregateMarketValue":375651.5,"unitsOutstanding":38284313,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-004004","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"NATHAN DOWDEN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15000,"aggregateMarketValue":217500,"unitsOutstanding":38284313,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-003138","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"KORY WENTWORTH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2500,"aggregateMarketValue":31550,"unitsOutstanding":38284313,"approxSaleDate":"2026-04-01","exchange":"NASDAQ","filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-002377","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"KORY WENTWORTH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16477,"aggregateMarketValue":207280.66,"unitsOutstanding":38284313,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-002366","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"NATHAN DOWDEN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15010,"aggregateMarketValue":188825.8,"unitsOutstanding":38284313,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-26-002210","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"KORY WENTWORTH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7988,"aggregateMarketValue":94657.8,"unitsOutstanding":38284313,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001950047-25-009207","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS INC","ticker":"TRDA","personName":"KORY WENTWORTH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8910,"aggregateMarketValue":81704.7,"unitsOutstanding":38219232,"approxSaleDate":"2025-11-21","exchange":"NASDAQ","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/trda"},{"accessionNo":"0001674324-25-000003","issuerCik":"0001689375","issuerName":"ENTRADA THERAPEUTICS, INC.","ticker":"TRDA","personName":"5AM Ventures V, L.P.","relationship":"Affiliated Stockholder","securityClass":"Common Stock","broker":"Goldman Sachs & Co. LLC","unitsToSell":200000,"aggregateMarketValue":1760664,"unitsOutstanding":38219232,"approxSaleDate":"2025-11-14","exchange":"Nasdaq","filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/trda"}],"updatedAt":"2026-11-05T11:43:35.878Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/trda","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}